ArticlePharmaceuticals (Basel, Switzerland)2023

Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis.

Masaki Gomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.